Medifast (MED) Income from Continuing Operations (2010 - 2026)

Medifast's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 2141000.0 for Q1 2026.

• Quarterly Income from Continuing Operations fell 176.61% year-over-year to 2141000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20000000.0 (down 187.98% YoY) and the FY2025 annual result came in at 18639000.0, down 991.39% from the prior year.
• Income from Continuing Operations was 2141000.0 for Q1 2026 at Medifast, up from 18082000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 41781000.0 in Q1 2022 and bottomed at 18082000.0 in Q4 2025.
• A 5-year average of 13195352.94 and a median of 6035000.0 in 2023 frame the typical range for Income from Continuing Operations.
• Peak annual rise in Income from Continuing Operations reached 130.43% in 2025, while the deepest fall reached 2357.43% in 2025.
• Medifast's Income from Continuing Operations stood at 26518000.0 in 2022, then sank by 77.24% to 6035000.0 in 2023, then sank by 86.73% to 801000.0 in 2024, then tumbled by 2357.43% to 18082000.0 in 2025, then soared by 88.16% to 2141000.0 in 2026.
• Business Quant data shows MED's Income from Continuing Operations at 2141000.0 in Q1 2026, 18082000.0 in Q4 2025, and 2257000.0 in Q3 2025.